Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Stem Cell Research
|
October 9, 2018
Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A)
Nicholas Brookhouser, Ping Zhang, Richard Caselli, et al.
Stem Cell Research
|
October 17, 2017
Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant
Nicholas Brookhouser, Ping Zhang, Richard Caselli, et al.
Stem Cell Research
|
December 17, 2017
Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant
Nicholas Brookhouser, Ping Zhang, Richard Caselli, et al.
Journal of Alzheimer'S Disease : JAD
|
February 23, 2024
Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment
Divya Prabhakaran, Caroline Grant, Otto Pedraza, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2021
Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
Anna K Edlund, Kewei Chen, Wendy Lee, et al.
Alzheimer'S Research & Therapy
|
February 1, 2017
Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism
Henrietta M Nielsen, Kewei Chen, Wendy Lee, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology
|
September 11, 2010
Computerized analysis of speech and language to identify psycholinguistic correlates of frontotemporal lobar degeneration
Serguei V S Pakhomov, Glenn E Smith, Dustin Chacon, et al.
Journal of Neurolinguistics
|
March 2, 2011
A computerized technique to assess language use patterns in patients with frontotemporal dementia
Serguei Vs Pakhomov, Glenn E Smith, Susan Marino, et al.
Alzheimer'S Research & Therapy
|
November 11, 2010
Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4
Daniel A Pollen, Stephen Baker, Douglas Hinerfeld, et al.
Mitochondrion
|
November 25, 2006
Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment
Jon Valla, Lonnie Schneider, Tracy Niedzielko, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Stem Cell Research
|
October 9, 2018
Generation and characterization of two human induced pluripotent stem cell (hiPSC) lines homozygous for the Apolipoprotein e4 (APOE4) risk variant-Alzheimer's disease (ASUi005-A) and healthy non-demented control (ASUi006-A)
Nicholas Brookhouser, Ping Zhang, Richard Caselli, et al.
Stem Cell Research
|
October 17, 2017
Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi001-A) and non-demented control (ASUi002-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant
Nicholas Brookhouser, Ping Zhang, Richard Caselli, et al.
Stem Cell Research
|
December 17, 2017
Generation and characterization of human induced pluripotent stem cell (hiPSC) lines from an Alzheimer's disease (ASUi003-A) and non-demented control (ASUi004-A) patient homozygous for the Apolipoprotein e4 (APOE4) risk variant
Nicholas Brookhouser, Ping Zhang, Richard Caselli, et al.
Journal of Alzheimer'S Disease : JAD
|
February 23, 2024
Machine Learning Predicts Conversion from Normal Aging to Mild Cognitive Impairment Using Medical History, APOE Genotype, and Neuropsychological Assessment
Divya Prabhakaran, Caroline Grant, Otto Pedraza, et al.
Journal of Alzheimer'S Disease : JAD
|
April 5, 2021
Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
Anna K Edlund, Kewei Chen, Wendy Lee, et al.
Alzheimer'S Research & Therapy
|
February 1, 2017
Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism
Henrietta M Nielsen, Kewei Chen, Wendy Lee, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology
|
September 11, 2010
Computerized analysis of speech and language to identify psycholinguistic correlates of frontotemporal lobar degeneration
Serguei V S Pakhomov, Glenn E Smith, Dustin Chacon, et al.
Journal of Neurolinguistics
|
March 2, 2011
A computerized technique to assess language use patterns in patients with frontotemporal dementia
Serguei Vs Pakhomov, Glenn E Smith, Susan Marino, et al.
Alzheimer'S Research & Therapy
|
November 11, 2010
Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4
Daniel A Pollen, Stephen Baker, Douglas Hinerfeld, et al.
Mitochondrion
|
November 25, 2006
Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment
Jon Valla, Lonnie Schneider, Tracy Niedzielko, et al.
Page
of 3